US Stock MarketDetailed Quotes

THAR Tharimmune

Watchlist
  • 1.430
  • -0.020-1.38%
Close Feb 28 16:00 ET
  • 1.430
  • 0.0000.00%
Post 20:01 ET
2.77MMarket Cap0.02P/E (TTM)

About Tharimmune Company

Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or \"uncontrollable itching\" in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolTHAR
Company NameTharimmune
Listing DateJan 12, 2022
Founded2017
CEOMr. Randy Milby
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address1200 Route 22 East,Suite 2000
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807
Phone1-908-955-3140

Company Executives

  • Name
  • Position
  • Salary
  • Randy Milby
  • Chief Executive Officer and Chairman of the Board
  • 742.42K
  • Sireesh Appajosyula
  • Director and Chief Operating Officer
  • 8.48K
  • Thomas P. Hess
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Sanam Parikh
  • Director
  • --
  • Kelly J. Anderson
  • Independent Director
  • 46.17K
  • Leonard L. Mazur
  • Independent Director
  • 34.43K
  • Dr. Lynne A. Bui, M.D.
  • Independent Director
  • 41.57K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More